IL6 and Myocardial fibrosis: We critically examine how loss-of-function mutations in epigenetic regulators promote a pro-inflammatory macrophage phenotype through NLRP3 inflammasome activation and IL-1β/IL-6 signaling, thereby accelerating atherogenesis, plaque instability, and myocardial fibrosis.